GLATIRAMER ACETATE HUMAN MONOCYTIC CELL LINE-BASED POTENCY ASSAY

摘要

The present invention relates to a method to determine the potency of a batch of glatiramer acetate comprising stimulating human monocytic cell line cells with an effective amount of interferon gamma (IFN³), exposing said cells to said batch of glatiramer acetate, and determining determining the number of metabolically active cells induced by glatiramer acetate.